MacroGenics clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-05
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 0 with minor changes only.
- Notable: MGC030 · Advanced Solid Tumors Recruitment opened
- Notable: MGC026 · Advanced Solid Tumors Enrollment increased: 250 → 394 participants
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1 | 4 | |
| Phase 2 | 1 |
Disease areas by active trials, top 10 of 24
Colorectal Cancer (3) · Pancreatic Cancer (3) · Bladder Cancer (2) · Cervical Cancer (2) · Endometrial Cancer (2) · Esophageal Cancer (2) · Gastric Cancer (2) · Lung Cancer (2) · Non-Small Cell Lung Cancer (NSCLC) (2) · Ovarian Cancer (2)
Get alerts when MacroGenics's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.